Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Norbert Galldiks, Michael Wollring, Jan-Michael Werner, Michel Friedrich, Gereon R. Fink, Karl-Josef Langen & Philipp Lohmann. (2022) An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET. Expert Review of Neurotherapeutics 22:11-12, pages 915-921.
Read now
Read now
Articles from other publishers (36)
Norbert Galldiks & Karl-Josef Langen. (2023)
Hybrid
18
F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors
. Journal of Nuclear Medicine 64:7, pages 1093-1094.
Crossref
Crossref
Jiaona Dai, Hui Wang, Yuchao Xu, Xiyang Chen & Rong Tian. (2023) Clinical application of AI-based PET images in oncological patients. Seminars in Cancer Biology 91, pages 124-142.
Crossref
Crossref
Olgun ŞAHİN, Hilal ŞAHİN & Mehmet Cem ÇALLI. (2023) Distinction of Pseudoprogression and Progression in Glioblastoma Multiforme After Treatment: Utility of Ratio of Decrease in rCBV and rCBF Values on Serial Perfusion MRIsGlioblastoma Multiforme'nin Tedavi Sonrası Psödoprogresyon ile Progresyon Ayrımı: Seri Perfüzyon MR Görüntülemelerde rCBV ve rCBF Değerlerinde Azalma Oranının Yararı. İzmir Tıp Fakültesi Dergisi 2:1, pages 15-21.
Crossref
Crossref
Antoine Seyve, Caroline Dehais, Olivier Chinot, Apolline Djelad, Elisabeth Cohen-Moyal, Charlotte Bronnimann, Carole Gourmelon, Evelyne Emery, Philippe Colin, Mathieu Boone, Elodie Vauléon, Olivier Langlois, Anna-Luisa di Stefano, Romuald Seizeur, François Ghiringhelli, Anne D’Hombres, Loic Feuvret, Jacques Guyotat, Laurent Capelle, Catherine Carpentier, Louis Garnier, Jérôme Honnorat, David Meyronet, Karima Mokhtari, Dominique Figarella-Branger & François Ducray. (2023) Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study. Neuro-Oncology 25:3, pages 495-507.
Crossref
Crossref
Ethan A Wetzel, Matthew J Farrell, Blaine S C Eldred, Vicki Liu, Ishan Saha, Serendipity Zapanta Rinonos, Terry Prins, Tie Li, Minsong Cao, John Hegde, Tania Kaprealian, Negar Khanlou, Linda M Liau, Phioanh Leia Nghiemphu, Timothy Francis Cloughesy, Robert A Chong, Benjamin M Ellingson & Albert Lai. (2023)
Retrospective examination of pseudoprogression in
IDH
mutant gliomas
. Neuro-Oncology Advances 5:1.
Crossref
Crossref
Samuele Ghezzo, Carolina Bezzi, Ilaria Neri, Paola Mapelli, Luca Presotto, Ana Maria Samanes Gajate, Valentino Bettinardi, Valentina Garibotto, Francesco De Cobelli, Paola Scifo & Maria Picchio. 2023. Clinical PET/MRI. Clinical PET/MRI
365
401
.
Michael M Wollring, Jan-Michael Werner, Elena K Bauer, Caroline Tscherpel, Garry S Ceccon, Philipp Lohmann, Gabriele Stoffels, Christoph Kabbasch, Roland Goldbrunner, Gereon R Fink, Karl-Josef Langen & Norbert Galldiks. (2022) Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET. Neuro-Oncology.
Crossref
Crossref
K. V. Gretskikh & A. S. Tokarev. (2022) High-grade gliomas: a literature review. Part 2. Radiosurgical treatment. Russian journal of neurosurgery 23:4, pages 87-98.
Crossref
Crossref
Meng-Yu Chen & Yue-Can Zeng. (2022) Pseudoprogression in lung cancer patients treated with immunotherapy. Critical Reviews in Oncology/Hematology 169, pages 103531.
Crossref
Crossref
Ahmed Abdel Khalek Abdel Razek, Ahmed Alksas, Mohamed Shehata, Amr AbdelKhalek, Khaled Abdel Baky, Ayman El-Baz & Eman Helmy. (2021) Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging. Insights into Imaging 12:1.
Crossref
Crossref
Theresa A Cook, Dasantha T Jayamanne, Helen R Wheeler, Matthew H F Wong, Jonathon F Parkinson, Raymond J Cook, Marina A Kastelan, Nicola J Cove, Christopher Brown & Michael F Back. (2021) Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma. Neuro-Oncology Practice 8:5, pages 601-608.
Crossref
Crossref
M. Scheer, C. Strauss, C. Scheller, C. Kubelt, M. Skalej, C. Mawrin & J. Prell. (2021) Case report of recurrent anaplastic oligodendroglioma with mixed astrocytic components and pathological discordance of tumor progression. Interdisciplinary Neurosurgery 25, pages 101195.
Crossref
Crossref
Ni Tong, Zhenqiang He, Yujie Ma, Zheng Wang, Ziming Huang, Haihong Cao, Lanyang Xu, Yuheng Zou, Wanyu Wang, Chenpeng Yi, Zhixin Yin & Qirui Wang. (2021) Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen & Norbert Galldiks. (2021)
Early Treatment Response Assessment Using
18
F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
. Journal of Nuclear Medicine 62:7, pages 918-925.
Crossref
Crossref
Mingxiao Li, Xiaohui Ren, Gehong Dong, Jincheng Wang, Haihui Jiang, Chuanwei Yang, Xuzhe Zhao, Qinghui Zhu, Yong Cui, Kefu Yu & Song Lin. (2021) Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features. Frontiers in Oncology 11.
Crossref
Crossref
Zaizhong Wang, Lulu Cheng, Zhigang Shang, Zhihui Li, Yuping Zhao, Wenwen Jin, Yingyue Li, Fangchu Su, Xiaobo Mao, Chuanliang Chen & Jianhua Zhang. (2021) Network Pharmacology for Analyzing the Key Targets and Potential Mechanism of Wogonin in Gliomas. Frontiers in Pharmacology 12.
Crossref
Crossref
Philipp Lohmann, Norbert Galldiks, Martin Kocher, Alexander Heinzel, Christian P. Filss, Carina Stegmayr, Felix M. Mottaghy, Gereon R. Fink, N. Jon Shah & Karl-Josef Langen. (2021) Radiomics in neuro-oncology: Basics, workflow, and applications. Methods 188, pages 112-121.
Crossref
Crossref
Clara Le Fèvre, Jean-Marc Constans, Isabelle Chambrelant, Delphine Antoni, Caroline Bund, Benjamin Leroy-Freschini, Roland Schott, Hélène Cebula & Georges Noël. (2021) Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers. Critical Reviews in Oncology/Hematology 159, pages 103230.
Crossref
Crossref
Guangyang Yu, Madison K. Butler, Abdalla Abdelmaksoud, Ying Pang, Yu-Ting Su, Zachary Rae, Kimia Dadkhah, Michael C. Kelly, Young K. Song, Jun S. Wei, Masaki Terabe, Ramya Atony, Kelly Mentges, Brett J. Theeler, Marta Penas-Prado, John Butman, Kevin Camphausen, Kareem A. Zaghloul, Edjah Nduom, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, Mark R. Gilbert, James L. Gulley, Javed Khan & Jing Wu. (2021) Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Francesco D’Amore, Farida Grinberg, Jörg Mauler, Norbert Galldiks, Ganna Blazhenets, Ezequiel Farrher, Christian Filss, Gabriele Stoffels, Felix M Mottaghy, Philipp Lohmann, Nadim Jon Shah & Karl-Josef Langen. (2021) Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Philipp Lohmann, Anna-Katharina Meißner, Martin Kocher, Elena K Bauer, Jan-Michael Werner, Gereon R Fink, Nadim J Shah, Karl-Josef Langen & Norbert Galldiks. (2020) Feature-based PET/MRI radiomics in patients with brain tumors. Neuro-Oncology Advances 2:Supplement_4, pages iv15-iv21.
Crossref
Crossref
Philipp Lohmann, Mai A. Elahmadawy, Robin Gutsche, Jan-Michael Werner, Elena K. Bauer, Garry Ceccon, Martin Kocher, Christoph W. Lerche, Marion Rapp, Gereon R. Fink, Nadim J. Shah, Karl-Josef Langen & Norbert Galldiks. (2020) FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation. Cancers 12:12, pages 3835.
Crossref
Crossref
Martin Kocher, Maximilian I. Ruge, Norbert Galldiks & Philipp Lohmann. (2020) Applications of radiomics and machine learning for radiotherapy of malignant brain tumors. Strahlentherapie und Onkologie 196:10, pages 856-867.
Crossref
Crossref
Theophilos Tzaridis, Katrin S Reiners, Johannes Weller, Daniel Bachurski, Niklas Schäfer, Christina Schaub, Michael Hallek, Björn Scheffler, Martin Glas, Ulrich Herrlinger, Stefan Wild, Christoph Coch & Gunther Hartmann. (2020) Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature. International Journal of Molecular Sciences 21:19, pages 7211.
Crossref
Crossref
Renata Belanova, Andrea Sprlakova-Pukova, Michal Standara, Eva Janu, Renata Koukalova, Jan Kristek, Petr Burkon, Ivana Kolouskova, Tomas Prochazka, Petr Pospisil, Arnab Chakravarti, Pavel Slampa, Ondrej Slaby & Tomas Kazda. (2020) In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region. Biomedical Papers 164:3, pages 307-313.
Crossref
Crossref
Soumen Khatua, Laurence J N Cooper, David I Sandberg, Leena Ketonen, Jason M Johnson, Michael E Rytting, Diane D Liu, Heather Meador, Prashant Trikha, Robin J Nakkula, Gregory K Behbehani, Dristhi Ragoonanan, Sumit Gupta, Aikaterini Kotrotsou, Tagwa Idris, Elizabeth J Shpall, Katy Rezvani, Rivka Colen, Wafik Zaky, Dean A Lee & Vidya Gopalakrishnan. (2020) Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro-Oncology 22:8, pages 1214-1225.
Crossref
Crossref
Jan-Michael Werner, Philipp Lohmann, Gereon R. Fink, Karl-Josef Langen & Norbert Galldiks. (2020) Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors. Molecules 25:6, pages 1471.
Crossref
Crossref
Yuelong Yang, Yunjun Yang, Xiaoling Wu, Yi Pan, Dong Zhou, Hongdan Zhang, Yonglu Chen, Jiayun Zhao, Zihua Mo & Biao Huang. (2020) Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas. Journal of Neuro-Oncology 146:2, pages 363-371.
Crossref
Crossref
E. Antonio Chiocca, John S. Yu, Rimas V. LukasIsaac H. SolomonKeith L. Ligon, Hiroshi NakashimaDaniel A. TriggsDavid A. Reardon, Patrick WenBrittany M. Stopa, Ajay NaikJeremy RudnickJethro L. Hu, Priya KumthekarBakhtiar Yamini, Jill Y. Buck, Nathan Demars, John A. BarrettArnold B. Gelb, John ZhouFrancois Lebel & Laurence J. N. Cooper. (2019) Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial. Science Translational Medicine 11:505.
Crossref
Crossref
Trond V. Bogsrud, Ayca Londalen, Petter Brandal, Henning Leske, Ioannis Panagopoulos, Per Borghammer & Tore Bach-Gansmo. (2019) 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma. Clinical Nuclear Medicine 44:8, pages 605-611.
Crossref
Crossref
Philipp Lohmann, Jan-Michael Werner, N. Shah, Gereon Fink, Karl-Josef Langen & Norbert Galldiks. (2019) Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients. Cancers 11:2, pages 153.
Crossref
Crossref
Bart R.J. van Dijken, Peter Jan van Laar, Marion Smits, Jan Willem Dankbaar, Roelien H. Enting & Anouk van der Hoorn. (2018) Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques. Journal of Magnetic Resonance Imaging 49:1, pages 11-22.
Crossref
Crossref
Anastasia Zikou, Chrissa Sioka, George A. Alexiou, Andreas Fotopoulos, Spyridon Voulgaris & Maria I. Argyropoulou. (2018) Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas. Contrast Media & Molecular Imaging 2018, pages 1-6.
Crossref
Crossref
Maike Trommer-Nestler, Simone Marnitz, Martin Kocher, Daniel Rueß, Max Schlaak, Sebastian Theurich, Michael von Bergwelt-Baildon, Janis Morgenthaler, Karolina Jablonska, Eren Celik, Maximilian Ruge & Christian Baues. (2018) Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment. International Journal of Molecular Sciences 19:9, pages 2653.
Crossref
Crossref
Philipp Lohmann, Martin Kocher, Jan Steger & Norbert Galldiks. (2018) Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 62:3.
Crossref
Crossref
Garry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, Marion Rapp, Manuel Weber, Tobias Blau, Phillip Lohmann, Sied Kebir, Ken Herrmann, Gereon R. Fink, Karl-Josef Langen, Martin Glas & Norbert Galldiks. (2018) Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience. European Journal of Nuclear Medicine and Molecular Imaging 45:9, pages 1626-1635.
Crossref
Crossref